Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin vs Levofloxacin in CAP
NCT01529476Phase 3Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of nemonoxacin in community acquired pneumonia (CAP), sponsored by TaiGen Biotechnology Co., Ltd.. Started Apr 2011; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01529476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529476.